8 results
6-K
EX-99.2
SOPH
SOPHiA Genetics SA
15 Jun 22
Current report (foreign)
11:07am
and transparency into our corporate structure We take the privacy of individuals seriously and pledge to respect the confidentiality of personal data
20-F
2021 FY
SOPH
SOPHiA Genetics SA
15 Mar 22
Annual report (foreign)
7:24am
on certain product access and marketing cost disclosure and transparency measures, which are, in some cases, designed to encourage importation from other … to evaluate and improve machine learning algorithms;
fostering a patient-centered approach, including device transparency to users;
developing
20-F
2021 FY
EX-4.10
SOPH
SOPHiA Genetics SA
15 Mar 22
Annual report (foreign)
7:24am
reserves the right to publicly disclose the Agreement to satisfy reasonable transparency and disclosure policies and/or reporting obligations
424B4
SOPH
SOPHiA Genetics SA
23 Jul 21
Prospectus supplement with pricing info
4:37pm
cost disclosure and transparency measures, which are, in some cases, designed to encourage importation from other countries and bulk purchasing … , including device transparency to users;
developing methods to evaluate and improve machine learning algorithms; and
advancing real-world performance
F-1/A
hemogwcti
19 Jul 21
Registration statement (foreign) (amended)
7:01am
F-1
nws5k
2 Jul 21
Registration statement (foreign)
4:17pm
DRS
utfzkacn4d3u1mfn
24 May 21
Draft registration statement
12:00am
- Prev
- 1
- Next